Trigger The Wonder Horse Author Angela Lenhardt to be Featured on Close Up Radio

DENVER, COLORADO, UNITED STATES, July 8, 2021 /EINPresswire.com/ — From the moment Trigger came into her life, Angela Lenhardt sensed he was a special horse, but she had no idea just how extraordinary his story would be or how much he would teach her and others.

Trigger the Wonder Horse is the true story of a heroic journey taught through the life of a palomino quarter horse. The book chronicles Angela and Trigger’s inspirational journey together and the phenomenal occurrences that earned him the nickname “Wonder Horse.”

“Trigger has an incredible gift to help people heal,” says Angela. “I believe all horses do but Trigger especially so. Horses are God's creatures. They're strong and courageous, and they know people better than most people know themselves because horses act as a mirror, and reflect back your own internal, emotional state. Horses teach us how to trust and communicate. I rescued Trigger, but in so many ways, he’s the one who rescued me.”

Angela has owned Trigger for 27 years! And if you think that’s a long time, Trigger is 43 years old! Trigger’s heartwarming story has touched countless lives around the world. He is a message of faith, hope and miracles.

“People ask me all the time, ‘How long do horses live?’ and Trigger has definitely lived a longer life than most horses,” says Angela. “Trigger is an extension of God’s love. Even though I own him, Trigger is a “community” project. He would not be alive without all the love he has received from everyone over the years, from the veterinary staff, caretakers, plus Trigger’s fan club. So many people give him unconditional love every single day, and Trigger does his best to return the favor.”

Angela’s relationship with Trigger has taught her so many powerful lessons—about love, trust, faith, perseverance and healing. She wrote this book with the intention that readers would benefit from these inspiring lessons as well.

“Horses teach us about relationships, but and most importantly, how to have a relationship with ourselves to become better people,” says Angela. “I wouldn’t be the person I am without his devotion to me and our companionship.

Still, Angela says she had no plans to write the book until Trigger went through an incredible health crisis.

“I was ready to let him go,” recalls Angela. “He walked himself over to where they euthanize the horses, and I thought this was a signal to me that he was done. I was sitting next to him crying, and I leaned down and whispered in his ear, “Are you ready to meet God?” All of a sudden, this horse that could barely walk, who was practically dead, stands up, looks at me and takes off running as fast as he possibly can. That was over five years ago, and he has inspired me every single day since.”

Today, she and Trigger attend charity events at foster homes, schools and churches to teach children about horses and give away the book.

“People are really looking for hope,” says Angela. “So Trigger the Wonder Horse is for anyone in need of a reminder that when life gets you down, and you’re faced with uncertainty and fear, grace is always present,”

Trigger the Wonder Horse is for horse lovers, pet lovers, young adults, new age readers, and those who appreciate spiritual insights and wisdom. Uplifting, heart-wrenching, and powerful, the story of Trigger the Wonder Horse will have you believing in miracles.

Says Angela: “My intention is to change how people treat horses one book at a time.”

Close Up Radio will feature Angela Lenhardt in an interview with Jim Masters on July 12th at 12pm EDT

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information, visit www.triggerthewonderhorse.com

Lou Ceparano
Close Up Television & Radio
+1 631-850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Robbin McManne, International Parenting Authority, Hand-selected to Contribute to Newsweek Expert Forum

Newsweek Expert Forum is an invitation-only community where pioneering thinkers and industry leaders go to share their up-to-the-minute ideas.

VANCOUVER, BRITISH COLUMBIA, CANADA, July 8, 2021 /EINPresswire.com/ — Robbin McManne, international parenting expert and founder of Parenting for Connection, has accepted an invitation to join Newsweek Expert Forum, an invitation-only community for pioneering thinkers and industry leaders.

McManne was hand-selected to join the community based on her proven expertise in educating parents on how to get more cooperation with their kids and more harmony in their home. McManne’s work focuses on building and strengthening the parent-child relationship so that children grow up with resilience, confidence, and strong emotional intelligence. She works with parents to help them understand their own emotions and frustrations in parenting, so they can help build their children’s sense of self without losing themselves in the process! Certified parent coach, author, mother, and sought-after public speaker, McManne works with parents and families worldwide.

Scott Gerber, the founder of Newsweek Expert Forum, says, "We are honored to accept Robbin McManne into the Newsweek Expert Forum. When experts gather in curated, private settings, they can share advice and build trusted relationships that further their mutual success. Robbin brings important insights about parenting as a professional and business leader to this community.”

As a member, McManne is part of a curated network of thought leaders from a broad range of influential industries and professions who share unique insights and analyses with one another and publish thought-provoking content.

“I’m thrilled to be a part of this distinguished group of thought leaders. I look forward to using the Newsweek Expert Forum to share my insights and expertise on raising our kids in today’s complicated and confusing environment. Never before has there been a more important time to consciously raise our kids and teach them how to thrive in tomorrow’s world.”

Of the total current Newsweek Expert Forum members, only a small number are in Canada, making this invite even more special to McManne. McManne loves working with clients from around the world but is based with her family in Vancouver, Canada.

Members of the Newsweek Expert Forum are top thinkers and professionals in business, culture/arts, health, lifestyle, money, science, sports, technology, and travel.

Newsweek is a premier news magazine and website that has been bringing high-quality journalism to readers around the globe for over 80 years. Newsweek provides the latest news, in-depth analysis, and ideas about international issues, technology, business, culture, and politics.

More about McManne, here: https://www.parentingforconnection.com/

About Robbin McManne:

Robbin is a Certified Parent Coach, author, podcaster and speaker. She works with parents from all over the world to help them build more connection and find more joy and cooperation to their parenting.

Robbin is a former ‘Angry Mom’ and for over 12 years, Robbin juggled a full-time corporate career while being a mom and wife, prior to becoming a Parenting Coach. In her corporate career, Robbin has a background in marketing and public relations, training, and event planning. She understands firsthand how many moms struggle to balance work and family.

It’s because of her struggles as a parent that she found the world of peaceful parenting and has dedicated her life to teaching parents how to build a strong family, so their kids thrive.

Robbin’s work focuses on building and strengthening the parent child relationship so that children grow up with resilience, confidence and strong emotional intelligence. She works with parents to help them understand their own emotions and frustrations in parenting, so they can help build their children’s sense of self without losing themselves in the process!

In October of 2018 Robbin released her first book, “The Yelling Cure – How to stress less and get your kids to cooperate without threats & punishments.” Her book is being read by parents all over the world with 300,000 copies sold to date.

Robbin divides her time working with her clients, speaking at events and spending time with her two boys and husband. You can usually find her at a hockey rink or sports field cheering on her boys. Most importantly, Robbin has changed the way she parents and connects with her sons and is dedicated to helping parents find the same joy, connection and cooperation in their families.

Sarah Snyder
+1 512-657-5648
email us here
Powerful Approach


Source: EIN Presswire

Another Healthcare Leader Re-Engages Tiller-Hewitt to Deliver Strategic Growth

For 20 years, Tiller-Hewitt HealthCare Strategies has partnered with healthcare organizations that want to consistently deliver strategic growth and measurable results.

For 20 years, Tiller-Hewitt HealthCare Strategies has partnered with healthcare organizations that want to consistently deliver strategic growth and measurable results.

Lake Charles Memorial Health System CEO Selects Tiller-Hewitt to Launch Initiatives for Service Line Growth, Physician Engagement and Retention

SAINT LOUIS, MO, UNITED STATES, July 8, 2021 /EINPresswire.com/ — Tiller-Hewitt HealthCare Strategies and Lake Charles Memorial Health System, southwest Louisiana's largest community-owned, non-profit healthcare system, have launched a strategic growth initiative focused on providing better access to high quality services throughout southwest Louisiana.

The Tiller-Hewitt team will collaborate with stakeholders to develop and implement data-driven performance improvements, access and capacity expansion, and outreach initiatives to deliver service line growth, physician engagement and retention.

“From partnering successfully with Tiller-Hewitt in the past, I am confident in their ability to deeply engage and enhance our growth in alignment with our business goals,” said Devon Hyde, MBA, who was named President and CEO of Lake Charles Memorial Health System in April 2021. “Their strategic growth program is an important part of our plans to foster a culture of motivation, respect and accountability and to help our team achieve top performance.”

“We’re very proud to have the opportunity to partner with Devon and the Lake Charles Memorial Health System team,” said Tammy Tiller-Hewitt, FACHE, Chief Executive Officer of Tiller-Hewitt HealthCare Strategies. “It’s a testament to the results of our programs when we hear from CEOs we’ve worked with in the past, who want us to re-engage with them and their new organization.”

Strategic Performance Improvement
As a strategic growth company, Tiller-Hewitt will collaborate with Memorial’s operational and clinical teams and position them to consistently deliver measurable results in strategic service lines.

Data-Driven Growth Strategies
“Robust data insights — based on relevant internal data, referral patterns and external claims information — will enable us to mitigate leakage, quantify growth opportunities and execute strategies to capitalize on those opportunities for Memorial,” said Thomas Tiller, chief operating officer of Tiller-Hewitt HealthCare Strategies.

Executing to Drive Strategic Growth
Tiller-Hewitt will identify, train and equip Memorial’s physician outreach liaisons with the powerful differentiator of being trusted advisors who deliver higher‐value solutions. The program will increase communication and build stronger relationships between the hospital physicians in employed and independent practices.

The disruption of the pandemic has spurred forward-thinking organizations across the U.S. to engage Tiller-Hewitt HealthCare Strategies for strategic growth recovery by embracing laser-focused data analytics, lean process improvement and retooled outreach teams. Tiller-Hewitt’s proven programs deliver strategic growth and measurable results: improving physician engagement, minimizing leakage, maximizing network utilization, protecting market share, and growing strategic, high-margin service lines and specialties.

About Lake Charles Memorial Health System
Lake Charles Memorial Health System is the region's largest not-for-profit, community healthcare system, serving the healthcare needs of southwest Louisiana. Memorial Health System is locally-owned and operated by a Board of Trustees from the community it serves. The hospital is a shareholder of Voluntary Hospitals of America (VHA), and is fully licensed by the Joint Commission on Accreditation of Healthcare Organizations. CEO Devon Hyde joined Lake Charles Memorial Hospital in 2021, bringing 15 years of healthcare leadership experience.

The only full-service healthcare system in Lake Charles, Memorial was established in 1952. Today, the health system includes 314 licensed beds on our Oak Park acute care campus, 54 beds at their Women's campus, 44 beds at their behavioral health campus and outpatient clinic serving uninsured and under insured at the Moss Memorial Health Clinic, and over 100 employed physicians and specialists that are a part of the Memorial Medical Group.

As the healthcare market leader in the Lake Charles region,their success can be attributed to a dedicated team of over 2,500 employees and 300 staff physicians representing more than 60 specialties and subspecialties, as well as the largest emergency services department and the only trauma center in southwest Louisiana. Memorial has the area's only teaching facility for physicians through the Memorial/LSUHSC Family Medicine Residency Program, and serves as a clinical training site for nursing, medical technology and radiologic technology students through various universities, including McNeese State University.

About Tiller-Hewitt
For 20 years, Tiller-Hewitt HealthCare Strategies has partnered with healthcare organizations that want to consistently deliver strategic growth and measurable results. The Tiller-Hewitt team designs and executes high-performance programs that drive strategic growth, network optimization, and physician retention for hundreds of health systems, hospitals, and population health and provider organizations nationwide.

Tiller-Hewitt delivers rapid, measurable return on investment by working as partners with leadership, operations and physician outreach/liaison teams to hardwire a collaborative culture and build strong strategic growth programs on the Tiller-Hewitt Pillars: Systems, Data and People. To learn more visit www.tillerhewitt.com.

Mary Barber
The Reputation Experts, LLC
+1 314-494-6952
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

سانوفي تنضم لـ"جناح فرنسا" في إكسبو 2020 دبي كشريك مواضيعي لعرض العلوم والابتكار

Research and innovation to improve health

France Pavilion, Expo 2020 Dubai

Erik Linquier, Commissioner General for France at Dubai World Expo and Chairman of Cofrex

Jean-Paul Scheuer, MCO Lead and General Manager Sanofi Genzyme, Greater Gulf, Sanofi

DUBAI, UAE, July 8, 2021 /EINPresswire.com/ —

أعلن "جناح فرنسا" المشارك في المعرض الدولي "إكسبو 2020 دبي" عن انضمام شركة "سانوفي" إليه كشريك مواضيعي. وخلال الفترة المخصصة للحديث عن القطاع الصحي من 21 يناير – 3 فبراير عام 2022، ستقوم سانوفي بالإعلان عن حلول طبية مبتكرة لتحسين جودة حياة الأفراد.

تطورت أهداف معارض إكسبو الدولية على مر السنين، ولكن الهدف الآن هو تعزيز التعاون الدولي والبحث عن حلول للتحديات الرئيسية التي تواجه البشرية. وعلى مدى ستة أشهر، ستجتمع جميع دول العالم معًا للتفكير في هذه التحديات وكيفية إيجاد حلول ملموسة لها. وفي ظل الأزمة الصحية الحالية، لم يعد هذا الموضوع مجرد اقتراح، وإنما ضرورة حتمية.

في إكسبو دبي، ستعمل فرنسا على تعزيز المواهب والأفكار والأصول الفرنسية، وسترسخ مكانتها كقوة دافعة وشريك دولي في تنفيذ أهداف التنمية المستدامة والمساهمة في بناء عالم ما بعد الأزمة الصحية. كما ستعرض فرنسا مبادراتها السياسية والاقتصادية والثقافية والاجتماعية المكرسة لبناء غد أفضل. ومن بين أهداف التنمية المستدامة، ستركز فرنسا بشكل كبير على دعم البحث والابتكار لتحسين قطاع الصحة.

“سيعمل الجناح الفرنسي على تعزيز المواهب الفرنسية التي تلعب دورًا في تنفيذ أهداف التنمية المستدامة والمساهمة في تقدّم البشرية. سيمنح معرض إكسبو 2020 دبي فرنسا منصة لدعم رؤيتها الجديدة للتنمية المسؤولة. وفي ضوء الأزمة الصحية التي نواجهها، نحن فخورون بالترحيب بـ"سانوفي" بين شركائنا لعرض ابتكاراتها من أجل غد أفضل."

إريك لانكيه،
المفوض العام لجناح فرنسا في إكسبو 2020 دبي ورئيس الشركة الفرنسية للمعارض "كوفريكس"

وعلى وجه الخصوص، ستقوم شركة سانوفي بعرض حلول وأنشطة تحت موضوع "دعم البحث والابتكار من أجل الصحة" الذي سيعقد في الفترة من 21 يناير إلى 3 فبراير 2022.

"نحن فخورون في سانوفي بشراكتنا مع الجناح الفرنسي في معرض إكسبو العالمي، والمساهمة في هذا الحدث الكبير ليس فقط بالنسبة للمنطقة وإنما لجميع أنحاء العالم. تظل الصحة أولوية قصوى خاصة في هذه الأوقات الحرجة، ويوفر لنا هذا المعرض فرصة مهمة لعرض خبراتنا وريادتنا كممثل عالمي في مجال الرعاية الصحية. ونحن نهدف إلى تسليط الضوء على علمنا وجهودنا البحثية والتطويرية والدور الحيوي الذي نقوم به لتقديم العلاجات والحلول المبتكرة. كما أن تعزيز المجالات ذات الأهمية الكبيرة لشعوبنا والتي تتسم بالتنوع والشمول هو مجال تركيز آخر نتطلع إلى تسليط الضوء عليه في إكسبو."

جان بول شوير،
رئيس ومدير عام شركة سانوفي بمنطقة الخليج

Vince Ang
New Perspective Media Group
+971 554739253
email us here


Source: EIN Presswire

Coronavirus (COVID-19) Current Therapy Options Include Convalescent Plasma Therapy

Coronavirus (COVID-19) Current Therapy Market Report 2021: COVID-19 Growth And Change To 2030

Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, July 8, 2021 /EINPresswire.com/ — Convalescent plasma therapy was used as an experimental therapy to treat COVID-19 patients. The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent plasma therapy is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to the patient with severe disease to suppress the virulence and improve clinical symptoms. The blood plasma of recovered COVID-19 patients have antibodies to fight the COVID-19 infection. According to guidance issued by the FDA, Convalescent Plasma Therapy was recommended as an investigational product during the public health emergency. By 30th April, 2020, around 2,004 participating sites adhering to a single expanded access protocol by the US FDA had been registered, around 7,774 patients had enrolled, and 3,809 of them had undergone convalescent plasma transfusion.

The global coronavirus (COVID-19) current therapy market size is expected to grow from $14.63 billion in 2020 to $16.8 billion in 2021 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The COVID-19 current therapy market is expected to reach $35.42 billion in 2025 at a CAGR of 20%.

Read More On The Global Coronavirus (COVID-19) Current Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/coronavirus-covid-19-current-therapy-market-global-report-2020-covid-19-growth-and-change

TBRC’s coronavirus (COVID-19) current therapy market report is segmented by drug type into antiviral (remdesivir, ritonavir, lopinavir), antimalarial (hydroxychloroquine), interferons (interferon beta), corticosteroid (dexamethasone), others, and by end-use into hospitals, clinics, research institutes, others.

Major players in the coronavirus current therapy market are Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, and Regeneron Pharmaceuticals.

Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides COVID-19 current therapy market overview, forecast COVID-19 current therapy market size and growth for the whole market, COVID-19 current therapy market segments, and geographies, COVID-19 current therapy market trends, COVID-19 current therapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Coronavirus (COVID-19) Current Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-market

Pharmaceutical Drugs And Biologics Logistics Market – By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbs), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-market

Antivirals Global Market Report 2021: COVID-19 Implications And Growth to 2030
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Antibody Drug Conjugates Market Players Are Increasingly Entering Into Collaborations And Partnerships For Expansion

Antibody Drug Conjugates Market Report 2021: COVID-19 Growth And Change To 2030

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, July 8, 2021 /EINPresswire.com/ — Manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business. For instance, in March 2019, Astrazeneca entered into a global development and commercialization collaboration agreement with Daiichi Sankyo Company for the proprietary antibody drug conjugate trastuzumab deruxtecan (DS-8201). In April 2019, Shanghai Miracogen entered into an agreement with Netherlands based Synaffix to use its tools for building antibody drug conjugates. According to the deal, Miracogen is licensing two platforms from Synaffix which is expected to boost its product pipeline.

The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. ADCs are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

Read More On The Global Antibody Drug Conjugates Market Report:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The global antibody drug conjugates market size is expected to grow from $2.34 billion in 2020 to $2.6 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antibody-drug conjugates (ADCs) market is expected to reach $6.12 billion in 2025 at a CAGR of 23.9%.

Major players in the antibody-drug conjugates (ADCs) industry are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., and Oxford BioTherapeutics.

TBRC’s antibody drug conjugates market report is segmented by type into monoclonal antibodies, linker, drug/toxin, others. The ADCs market is also segmented by application into blood cancer, breast cancer, ovarian cancer, lung cancer, brain tumor, others; by product into adcertis, kadcyla, others; by technology into immunogen technology, seattle genetics technology, immunomedics technology, others; by end user into hospital, clinics, others.

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides antibody drug conjugates market overview, forecast antibody drug conjugates market size and growth for the whole market, antibody drug conjugates market segments, and geographies, antibody drug conjugates market trends, antibody drug conjugates market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Antibody Drug Conjugates Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Monoclonal Antibodies (MAbs) Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-mabs-global-market-report

Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/immunosuppressants-global-market-report-2020-30-covid-19-growth-and-change

Molecular Diagnostics Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth to 2030
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Sanofi is named Thematic Sponsor of France Pavilion at Dubai World Expo to showcase science and innovation, among others

Research and innovation to improve health

France Pavilion, Expo 2020 Dubai

Erik Linquier, Commissioner General for France at Dubai World Expo and Chairman of Cofrex

Jean-Paul Scheuer, MCO Lead and General Manager Sanofi Genzyme, Greater Gulf, Sanofi

DUBAI, UAE, July 8, 2021 /EINPresswire.com/ —

The France Pavilion at Expo 2020 Dubai is delighted to welcome Sanofi as Thematic Sponsor. During the fortnight dedicated to Health from January 21st to February 3rd, 2022, Sanofi will unveil connected health solutions to improve the patients’ lives.

World Expos’ objectives have evolved over the years, but their goal is now to enhance international cooperation and the search for solutions to major human challenges. Over a six-month period, all the countries in the world will come together to think about the challenges that humanity is facing and how concrete solutions can be found. In light of the current health crisis, this theme is no longer just a suggestion, it is an imperative.

In Dubai, France will promote French talents, ideas and assets, and will position itself as an international driving force for implementing the Sustainable Development Goals (SDGs) and for building the post-health crisis world. France will showcase political, economical, cultural and social actions and initiatives dedicated in building a better tomorrow. Amongst these SDGs, a major focus will be made on supporting research and innovation to improve health.

“The France Pavilion will promote French talents that play a role in implementing the SDGs and contribute to human advance. The Dubai 2020 Expo will therefore give France a platform to champion its new vision for responsible development. In light of the health crisis we are facing, we are particularly proud to welcome Sanofi among our sponsors to showcase its innovations for a better tomorrow.”

Erik Linquier,
Commissioner General for France at Dubai World Expo and Chairman of Cofrex

Specifically, Sanofi will drive the activities under the “Supporting Research and Innovation for Health” theme to be held from 21 January 2022 to 3 February 2022.

“At Sanofi, we are proud to be partnering with the France Pavilion at Dubai World Expo, actively contributing to this major event not only for the region but also worldwide. Health remains a top priority especially at these critical times, and this gathering provides us an important opportunity to showcase our expertise and leadership as a global healthcare actor. We aim to underscore our science, our research and development efforts and the vital work we do to deliver innovative treatments and solutions. Advancing matters of great importance to our people, including diversity and inclusion, is another focus area we look forward to highlighting in the Expo.”

Jean-Paul SCHEUER,
MCO Lead and General Manager Sanofi Genzyme, Greater Gulf, Sanofi

Vince Ang
New Perspective Media Group
+971 554739253
email us here


Source: EIN Presswire

ISO-Aire™ EXPANDS LINE OF COMMERCIAL HEPA AIR PURIFICATION SOLUTIONS WITH LAUNCH OF RSF2000 AND RSF250 MODELS

The ISO-Aire RSF250 compact commercial air purifier brings healthy, sanitized air to small- and mid-sized spaces such as classrooms and waiting rooms. The RSF250 features two levels of clean air technology: HEPA filtration and ozone-free bipolar ionization.

New to the commercial air purifier category, the ISO-Aire RSF2000 is built to effectively purify the air inside larger spaces such as gymnasiums, cafeterias, performance halls, and community living areas.

ISO-Aire delivers proven COVID-19 mitigation strategies that are recommended for indoor air quality established by ASHRAE and the Centers for Disease Control for commercial applications, schools, healthcare facilities, and residential spaces.

Indoor Air Quality Leader Bookends Portfolio with Two Powerful Air Purifiers to Deliver Unmatched Indoor Air Quality Solutions for Spaces of all Sizes

We are proud to manufacture ISO-Aire in the U.S., creating unmatched air quality solutions that will protect our communities from harmful indoor pollutants and pathogens today and for years to come.”

— Chuck Albers, owner of Ducts & Cleats, St. Paul, MN

SAINT PAUL, MINNESOTA, UNITED STATES, July 8, 2021 /EINPresswire.com/ — America’s premium line of ISO-Aire™ commercial HEPA air purifiers today unveiled two high-performance models to ensure indoor spaces – from classrooms to large performance areas – are protected when it comes to safe, sustainable indoor air quality (IAQ). Powerful and proven in their respective categories, the RSF2000 and RSF250 are equipped with multiple layers of medical-grade clean air technology to continuously capture and destroy 99.99% of harmful pathogens and airborne pollutants . Born out of the COVID-19 pandemic over a year ago, ISO-Aire safeguards occupants bringing healthy indoor air to school classrooms, libraries, day care centers, gyms, places of worship, and office locations throughout the U.S.

Built To Purify Larger Spaces
The RSF2000 – the largest and most powerful model in the ISO-Aire line of elite purifiers – emits 2,000 cubic feet of sanitized air per minute throughout a given space. The portable HEPA air purifier delivers on-demand, extensive clean air purification coverage in large-sized office spaces, manufacturing facilities, cafeterias, gymnasiums, assembly halls, staging areas, open floor spaces, and community living areas. Known for its strategic air-throw capabilities, ISO-Aire utilizes a high-performance fan to push purified air at a high velocity into a room or area in a multi-directional trajectory more than 100 feet. This purposefully engineered approach ensures sanitized air is distributed precisely and evenly to maintain a safe breathing zone.

Recently two RSF2000 units were installed inside the Heinz Hall for the Performing Arts, Pittsburgh, Penn., as part of the Pittsburgh Symphony Orchestra’s proactive steps to bring healthcare-grade purified air to their performance and staging spaces. Both ISO-Aire RSF2000 models feature three levels of leading clean air technology including a 12-inch deep HEPA filter, UVC sterilization, and ozone-free bipolar ionization.

“For a legacy destination like Pittsburgh’s treasured Heinz Hall for the Performing Arts, home of the world-renowned Pittsburgh Symphony Orchestra, utilizing a proven in-space air purification solution was the most effective and efficient approach to bring sanitized, safe air to this historic landmark. The supplemental units are well-suited for the stage and auditorium to ensure adequate clean air coverage throughout these targeted areas and to reduce risk of contaminants within the breathing zone,” explained Rob Kania, president, Direct Safety Solutions, who oversaw the installation. “Safeguarding these spaces to ensure the optimum air quality illustrates the proactive steps underway by the Orchestra protect against COVID-19, emerging variants, and other airborne contaminants.”

Dominating The Competition: RSF250
The ISO-Aire RSF250 assumes its category leadership as a compact, yet mighty 250 CFM air purifier built to protect occupants in small- to mid-sized spaces such as conference rooms, reception areas, smaller retail shops, classrooms, salons, waiting rooms, apartments, and homes. RSF250 models are engineered with medical-grade, 12-inch deep HEPA filtration and optional ozone-free bipolar ionization. The most powerful unit in its class, the RSF250 creates a healthy space by capturing and destroying 99.99% of harmful viruses and emerging variants as well as bacteria, mold, pollen, dust, and other pollutants. Most similar-sized air purifiers are made of plastic parts and substandard components, and they cannot meet nor exceed the RSF250’s capacity to recirculate indoor air while achieving the recommended air changes per hour (ACH) for a given space.

RSF2000 and RSF250 Product Specifications
ISO-Aire commercial units deliver proven COVID-19 mitigation strategies recommended for indoor air quality established by ASHRAE and the Centers for Disease Control. The air purifiers are engineered with variable-speed ECM fans, quality components, and are sound attenuated to ensure they are the quietest in category. With a lifespan of up to 20 years, ISO-Aire units are built to last in the U.S. with 22-guage embossed steel and rugged rolling casters for portability.

RSF2000:
• Dimensions: 30" x 30" x 85.25" (with or without UVC);
• Weight: 350 lbs. (without UVC), 360 lbs. (with UVC);
• Low noise, produces 37-60 dBA;
• Available with HEPA filtration as well as optional ozone-free bipolar ionization and/or UVC sterilization;
• Up to approximately 15,000 square feet or 1 air change/hour (ACH), or approximately 7,500 square feet with 2 ACH as recommended by ASHRAE and CDC guidelines.

RSF250:
• Dimensions: 15” x 15” x 32”;
• Weight: approximately 60 lbs.;
• Low noise, produces 40-56 dBA;
• Available with HEPA filtration and optional ozone-free bipolar ionization;
• Up to approximately 1,875 square feet or 1 ACH, or approximately 940 square feet with 2 ACH as recommended by ASHRAE and CDC guidelines.

“ISO-Aire was developed and purpose-built to address COVID-19 and other droplet and airborne-based infections in healthcare settings, and now we offer that same level of unsurpassed protection for school classrooms, churches and childcare centers,” explained Chuck Albers, developer of ISO-Aire and owner of parent company Ducts & Cleats. “There are too many plastic, throw-away purifiers that will not hold up to commercial applications. Hard-working, industrial ISO-Aire delivers on all fronts – from smart design and premier parts to proven technology and rugged construction. We are proud to manufacture ISO-Aire in the U.S., creating the solutions that will protect our communities from harmful indoor pollutants and pathogens today and for years to come.”

RSF2000 and RSF250 join ISO-Aire’s family of floor-set and hanging units featuring the same powerful medical-grade clean air technology and unmatched protection. Floor-set portable units include RSF300, RSF500, RSF1000, RSP1000; hanging units include RSH800 and RSH1000.

Albers and his team originally developed ISO-Aire at their St. Paul facility in early 2020 at the request of one of Minnesota’s leading healthcare facilities in response to creating negative pressure hospital isolation rooms for patients with COVID-19. Adapting the unit for commercial use, they redesigned ISO-Aire to accommodate a variety of building environments and applications. Albers emphasized one of the most important safeguards during the pandemic and beyond is improving and maintaining IAQ and removing harmful contaminants to protect one another.

For more details on model specifications, pricing, and to determine which ISO-Aire unit is the appropriate solution for your school or business, please email info@ductsandcleats.com, or call 651-265-0605.

Kevin Albers
Ducts & Cleats
+1 651-265-0607
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

ISO-Aire commercial air purifiers equipped with medical-grade HEPA filtration range from 250 CFM to 2000 CFM.


Source: EIN Presswire

mLogica Earns AWS Migration Competency

Tools/Methodology/Experience to migrate legacy database and mainframe applications to the cloud

Tech innovator says collaboration with AWS shows automated cloud migration gaining global momentum

NEW YORK, NY, USA, July 8, 2021 /EINPresswire.com/ — mLogica, a global provider of database, mainframe and application modernization services, with deep experience in the legacy modernization market, announced today that it has achieved Amazon Web Services (AWS) Migration Competency status. The designation recognizes that mLogica offers proven tools, services, methodologies—as well as years of customer success migrating databases, mainframes and applications to AWS.

Achieving the AWS Migration Competency status differentiates mLogica as an AWS Partner with a track record of success and deep domain expertise in migrating databases, mainframes and applications to the cloud.

Migration to the cloud is increasingly vital for businesses that want to stay competitive, however it requires experienced partners with proven tools and successful, repeatable methodologies to ensure security, accuracy, timeliness and minimal disruption to business. The AWS Partner Network (APN) gives customers looking to migrate to the cloud on AWS access to mature technology products and services for mainframe, application and database migrations with proven solutions and expertise.

“Every business worldwide is on a path to the cloud; that’s how IT will be managed in the future,” says Amit Okhandiar, president and CEO of mLogica. “And while many companies have already migrated their simpler databases and applications, we’re now at the point where business and governmental agencies are finding it increasingly difficult to find staff trained to support their decades-old legacy systems. These workloads are also typically mission-critical and highly complex, with many upstream and downstream applications and interfaces. Modernization and migration to the cloud through automation is the key strategy for success going forward.”

Continues Okhandiar, “The mLogica approach to the modernization and migration of workloads to AWS is through automation, which includes assessment software, compilers for re-platforming, and translation software for refactoring of legacy languages such as COBOL to more modern object-oriented language such as C++ or Java.”

Okhandiar feels mLogica’s role is vital for cloud migration minus the headaches. “Our exclusive software tools, including our STAR*M automated migration software portfolio for distributed workloads and LIBER*M portfolio for mainframe workloads, are among the best options to securely transition to the cloud cost-effectively and with minimal disruption to your staff and your business.”

AWS enables scalable, flexible, and cost-effective cloud solutions for everyone, from startups to global enterprises, and established its AWS Competency Program to help customers identify AWS Partners, like mLogica, with long-term industry expertise to support seamless integration and deployment of these solutions.

mLogica has successfully completed over 600 modernization projects worldwide for customers in key sectors including healthcare, financial services, manufacturing, telecommunications, retail and more, in addition to federal and state agencies.

mLogica achieved the AWS Migration Competency designation based on its demonstrated experience and understanding of the business needs of organizations looking to transition to the cloud, as well as the tech firm’s exclusive tools that automate complex code translations, saving customers money by reducing timelines and costly human error.

Says Okhandiar, “By achieving the AWS Migration Competency designation, mLogica is expanding its collaboration with AWS, making it an integral component of our mission. Since our founding in 2004, mLogica has built strong relationships with key global cloud providers and systems integrators, enabling some of the largest customers worldwide to modernize their mission-critical, enterprise environments via our automated migration technologies.”

About mLogica
mLogica’s mission is to help drive enterprise efficiency through cloud migration. Founded by professionals from leading technology companies, mLogica specializes in migrating complex, legacy on-premise business applications and databases, both mainframe and distributed, to the cloud.

mLogica leverages its automated distributed systems modernization software suite STAR*M, and their mainframe modernization software, LIBER*M, to migrate legacy systems to the cloud. mLogica also modernizes big data applications with their hyperscale petabyte+ big data software CAP*M, and their software-driven TRAK*M managed services programs.

For more information, visit https://www.mLogica.com

Michael Kane
mLogica, LLC
michael.kane@mlogica.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

DRUG-FREE WORLD FOUNDATION WEBINAR AIMS TO HELP REVERSE 2021 UNWORLD DRUG REPORT TRENDS

Keynote Speaker Akira Fujino

DFW Hungary Gregory Nemeth

Youth Sign Drug Free Pledge at Steered Straight Rally

International Day Against Drug Abuse and Illicit Trafficking – Foundation for a Drug-Free World held an international webinar -"Learn, Collaborate, Empower.”

LOS ANGELES, CA, US, July 8, 2021 /EINPresswire.com/ — DRUG-FREE WORLD FOUNDATION WEBINAR AIMS TO HELP REVERSE 2021 UN WORLD DRUG REPORT TRENDS

To commemorate the June 26th, International Day Against Drug Abuse and Illicit Trafficking, the Foundation for a Drug-Free World held an international webinar. Entitled, “The Truth About Drugs – Learn. Collaborate. Empower.” The Foundation brought together drug prevention experts who shared best practices with hundreds of concerned educators, parents and community leaders from 35 countries.

Held the day before the release of the 2021 World Drug Report of the United Nations Office on Drugs and Crime (UNODC), “Learn. Collaborate. Empower.” could not have been more timely in light of the reported statistics:
• A 22 percent increase in the number of drug users between 2010 and 2019.
• 275 million drug users worldwide, compared to 269 million from the previous report.
• Since the COVID-19 pandemic, more users have turned to the drug markets on the dark web, now a $315 million annual business.

Jessica Hochman, Executive Director of the Foundation for a Drug-Free World, emceed the conference that was based on the UNODC theme of the 2021 International Day Against Illicit Drug Trafficking, “Share facts on Drugs, Save Lives”, emphasizing the vital role drug education plays in helping people make informed decisions concerning drug use.

The speakers, all experts in drug education and prevention, addressed the vital necessity of primary prevention to revert the UNODC 2021 World Drug Report trends. Mr. Akira Fujino, President of Drug Abuse Prevention Centre of Japan, a former 25 year UNODC executive, highlighted the need for the general public to receive accurate information on drugs. For example, most people are not informed that cannabis today has up to 15.6 percent THC—a four times increase in the past 24 years. Fujino stressed the importance of prevention and credits the recent containment of the drug rate in Japan to the implementation of the Truth About Drugs campaign in the country: an increase of only 1.8 percent.

Michael DeLeon, founder of the non-profit group, Steered Straight, Inc., and the #1 booked school presenter in America, has lectured to more than 10 million students in centers and schools across the United States since 2007. As a former drug addict, he decided to turn his life around and made it his life's goal to keep youth safe from the dead end of drugs through drug education. DeLeon spoke of the ravages of the painkiller fentanyl and stressed that the growth of THC and CBD are an American crisis. In answer to the question, "Which drug is the most dangerous?" DeLeon said, "The one you are addicted to." He sees drug prevention as vital to countering the drug epidemic.

Gregory Nemeth, Executive Director of the Foundation for a Drug-Free World Hungary and the Foundation's Central European Coordinator, shared what he has learned through a decade of drug education and coordinating volunteers. Through the work of the Foundation volunteers, they have built an alliance of 520 member organizations dedicated to drug prevention across Central Europe.

Dr. Greg Londot, Parent Teacher Association Teacher of the Year awardee and experienced public school drug educator from Phoenix, Arizona, spoke of his use of The Truth About Drugs Education Package in a classroom setting. Dr. Londot shared stories from his students including one living with their crack-cocaine addicted parents and remembered the sadness of losing kids he personally knew to drug overdoses, driving his passion for drug education. He created "Drug-Free Fridays"—a day each week when students may safely share intimate experiences about drugs and learn about drug use through the Truth About Drugs curriculum.

In concluding the webinar, the Foundation for a Drug-Free World Executive Director, Jessica Hochman, encouraged those attending to use the free online resources available at drugfreeworld.org. The popular Truth About Drugs eCourse, is a series of interactive courses providing basic facts about the most commonly used drugs. It includes stories from real people, and is designed to empower viewers with factual information. The Truth About Drugs eCourse is free to anyone at drugfreeworld.org/course and is available in 20 languages.

The Foundation is celebrating its 15th Anniversary of service devoting its resources to teaching the Truth About Drugs to youth around the world. The Foundation is proudly sponsored by the Church of Scientology and its members and provides the materials and program free of cost to educators and drug prevention advocates, schools, community groups, law enforcement and governmental institutions worldwide.

The webinar can be viewed on the Drug-Free World FB page: www.facebook.com/DrugFreeWorldInt.
For more information contact the Foundation for a Drug-Free World at news@drugfreeworld.org Phone: 818-952-5260

Jessica Hochman
Foundation For A Drug-Free World
+1 818-952-5260
email us here


Source: EIN Presswire